Ending the HIV Epidemic Among Women in AmericaSmith).pdfEnding the HIV Epidemic Among Women in...

Post on 04-Feb-2021

6 views 0 download

Transcript of Ending the HIV Epidemic Among Women in AmericaSmith).pdfEnding the HIV Epidemic Among Women in...

  • Ending the HIV Epidemic Among Women in America

    Dawn K. Smith, MD, MS, MPHEpidemiology Branch, Division of HIV/AIDS PreventionNational Center for HIV, Viral Hepatitis, STD, and TB Prevention11 February 2020

  • Ending the HIV Epidemic: A Plan for America

  • Diagnoses of HIV Infection among Female Adults and Adolescents, by Race/Ethnicity, 2010–2017—United States and 6 Dependent Areas

    a Hispanics/Latinos can be of any race.

  • Rates of Diagnoses of HIV Infection among Adults and Adolescents by Sex and Race/Ethnicity, 2018—United States

    Note. Data for the year 2018 are considered preliminary and based on 6 months reporting delay.a Hispanics/Latinos can be of any race.

  • New Diagnoses in Women: Race/Ethnicity by Region, 2018

  • Lifetime Risk of HIV Diagnosis Among Women by Race/Ethnicity

    Black/African American

    Hispanic/Latina

    White

    American Indian/Alaskan Native

    Native Hawaiian/Pacific Islander

    Asian

    Women

    1 in 54

    1 in 943

    1 in 432

    1 in 403

    1 in 256

    1 in 941

    Lifetime risk of ovarian cancer 1 in 70

  • Knowledge of HIV-Positive Status

    70

    80

    90

    100

    Sex

    % o

    r per

    sons

    with

    HIV

    infe

    ctio

    n w

    ho

    know

    thei

    r sta

    tus

    2017

    Male Female

  • Persons Living with Diagnosed or Undiagnosed HIV Infection HIV Care Continuum Outcomes, by Sex, 2016—United States

    Note. Receipt of medical care was defined as ≥1 test (CD4 or VL) in 2016. Retained in continuous medical care was defined as ≥2 tests (CD4 or VL) ≥3 months apart in 2016. Viral suppression was defined as

  • 0%10%20%30%40%50%60%70%80%90%

    100%

    Persons Transmissions

    Undiagnosed HIV+Diagnosed but not in careIn care but not virally suppressed

    HIV Transmission in the Care Continuum

    0

    20

    43

    38

    51

    11

    23

    15

  • Viral Suppression Among Women% Time with viral load >1500 copies/ml, 2014

    0102030405060708090

    100

    Sex% o

    f pe

    rson

    s with

    dia

    gnos

    ed H

    IV

    Male Female

    Viral Suppression, 2017

  • Age-Adjusted* Average Rates of Death with HIV Infection as the Underlying Causeby Sex and Race/Ethnicity, 2013−2017 — United States

    *Standard age distribution of 2000 US population**Hispanics/Latinos can be of any race.

    In 2017, HIV was the 9th leading cause of death for women ages 25-44 years)

  • Estimated Persons Prescribed PrEP, 2012-2019

    02012 2013 2014 2015 2016 2017 2018 2019

    Number of Persons Prescribed PrEP by Sex (AIDSVu)

    Males Females

    50,000

    100,000

    150,000

    200,000

    250,000

    *

    *Gilead 2019 estimate, Truvada or Descovy for PrEP

    0

    1,000

    2,000

    3,000

    4,000

    5,000

    6,000

    7,000

    8,000

    2012

    2013

    2014

    2015

    2012

    2013

    2014

    2015

    2012

    2013

    2014

    2015

    2012

    2013

    2014

    2015

    Females MalesWhite Hispanic/Latino African American Asian

    PrEP Starts

  • Preliminary Estimate:PrEP Coverage by Race Ethnicity, 2018

    0 10 20 30 40 50%

    Indications Coverage

    Hispanic

    Black

    White

  • HIV Diagnoses 2009-2014

    Transgender Women

  • New HIV Diagnoses, Female and Transgender Female, 2018

    0

    200

    400

    600

    800

    1000

    1200

    NYC WA CA FL LA NC

    Num

    ber p

    erso

    ns d

    iagn

    osed

    with

    HIV

    Female Transgender Female

  • In 2018, 1 in 5 new diagnoses were in women Women are below levels needed to achieve EHE goals

    – 89% of women with HIV know their status– 53% of women with HIV were virally suppressed in 2016– 61% of women with diagnosed HIV were virally suppressed in 2017– 7% of women with indications for PrEP received a prescription in 2018

    To achieve EHE goals, it is necessary to– Identify, implement, and evaluate the effectiveness of women-focused

    strategies and activities targeting the three EHE goals– Monitor the impact of EHE efforts on HIV diagnoses among women

    Ending the HIV Epidemic Among Women

  • Dr. Dawn K. Smithdsmith1@cdc.gov404.429.0904

    mailto:dsmith1@cdc.gov

    Ending the HIV Epidemic Among Women in America� �Dawn K. Smith, MD, MS, MPH�Epidemiology Branch, Division of HIV/AIDS Prevention�National Center for HIV, Viral Hepatitis, STD, and TB Prevention�11 February 2020���Ending the HIV Epidemic: A Plan for AmericaKey actions to help end the HIV epidemicNew HIV Diagnoses in the US and Dependent Areas for the Most-Affected Subpopulations, 2018Diagnoses of HIV Infection among Female Adults and Adolescents, by Race/Ethnicity, 2010–2017—United States and 6 Dependent Areas�Rates of Diagnoses of HIV Infection among Adults and Adolescents �by Sex and Race/Ethnicity, 2018—United StatesNew Diagnoses in Women: Race/Ethnicity by Region, 2018Lifetime Risk of HIV Diagnosis Among Women by Race/EthnicityKnowledge of HIV-Positive Status �Persons Living with Diagnosed or Undiagnosed HIV Infection �HIV Care Continuum Outcomes, by Sex, 2016—United States HIV Transmission in the Care ContinuumViral Suppression Among WomenAge-Adjusted* Average Rates of Death with HIV Infection as the Underlying Cause�by Sex and Race/Ethnicity, 2013−2017 — United StatesEstimated Persons Prescribed PrEP, 2012-2019Preliminary Estimate:�PrEP Coverage by Race Ethnicity, 2018Transgender WomenNew HIV Diagnoses, Female and Transgender Female, 2018Ending the HIV Epidemic Among WomenSlide Number 19